Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer’s disease

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Observations on the brains of demented old people

Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084

Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962

Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques

Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225

A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study

Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987

MALARIAL DIABETES

Rau, L. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91789-9 · Cited by 828

Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration

Yu, R., Deochand, C., Krotow, A., Leão, R. A. C., Tong, M., Agarwal, A., Cadenas, E., & de la Monte, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150751 · Cited by 48

Insights into White Matter Damage in Alzheimer's Disease: From Postmortem to in vivo Diffusion Tensor MRI Studies

Caso, F., Agosta, F., & Filippi, M. (2015) · Neurodegenerative Diseases · doi:10.1159/000441422 · Cited by 47

Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET

Callen, D. J. A., Black, S. E., & Caldwell, C. B. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0816-3 · Cited by 48

Metastable neural dynamics in Alzheimer's disease are disrupted by lesions to the structural connectome

Alderson, T. H., Bokde, A. L. W., Kelso, J. A. S., Maguire, L., & Coyle, D. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.08.033 · Cited by 46

Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease

de la Monte, S. M., & Bloch, K. D. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815155 · Cited by 47

Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer’s Disease Development in Mexico City Young Females

Calderón‐Garcidueñas, L., & de la Monte, S. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161299 · Cited by 50

Increasing loss of brain tissue with increasing dementia: a stereological study of post‐mortem brains from elderly females

Regeur, L. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00017.x · Cited by 44

What can DTI tell about early cognitive impairment?—Differentiation between MCI subtypes and healthy controls by diffusion tensor imaging

Gyebnár, G., Szabó, Á., Sirály, E., Fodor, Z., Sákovics, A., Salacz, P., Hidasi, Z., Csibri, É., Rudas, G., Kozák, L. R., et al. (2018) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2017.10.007 · Cited by 49

Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Dise ase Pathologies

Tong, M., & Dominguez, C. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000238 · Cited by 43

Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases

Sohn, Y. K., Ganju, N., Bloch, K. D., Wands, J. R., & de la Monte, S. M. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00297-4 · Cited by 44

Modulation of the Innate Immune Response by NMDA Receptors Has Neuropathological Consequences

Glezer, I., Zekki, H., Scavone, C., & Rivest, S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11094.2003 · Cited by 42

Medial temporal lobe atrophy in memory disorders

Pasquier, F., le Hamon, M. X. E., Lebert, F., Jacob, B., Pruvo, J., & Petit, H. (1997) · Journal of Neurology · doi:10.1007/s004150050069 · Cited by 41

White matter alterations in Alzheimer’s disease without concomitant pathologies

Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38

The Role of Quantitative Structural Imaging in the Early Diagnosis of Alzheimer's DiseaseQ4

Głodzik-Sobańska, L., Rusinek, H., Mosconi, L., Li, Y., Zhan, J., Santi, S. D., Convit, A. J., Rich, K. E., Bryś, M., & de Leon, M. J. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.004 · Cited by 40

NONSPECIFIC LEUKOENCEPHALOPATHY ASSOCIATED WITH AGING

Golomb, J. B., Kluger, A., Gianutsos, J. G., Ferris, S. H., de Leon, M. J., & GEORGE, A. E. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00274-6 · Cited by 40

Measurement of medial temporal lobe atrophy in diagnosis of Alzheimer's disease

de Leon, M. J., Golomb, J. B., Convit, A. J., DeSanti, S., McRae, T. D., GEORGE, A. E., Jobst, K. A., & Smith, A. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)92610-6 · Cited by 39

White matter lesions and temporal lobe atrophy related to incidence of both dementia and major depression in 70‐year‐olds followed over 10 years

Gudmundsson, P., Olesen, P. J., Simoni, M., Pantoni, L., Östling, S., Kern, S., Guo, X., & Skoog, I. G. (2015) · European Journal of Neurology · doi:10.1111/ene.12651 · Cited by 38

Decreased Oligodendrocyte Nuclear Diameter in Alzheimer's Disease and Lewy Body Dementia

Gagyi, E., Kormos, B., Castellanos, K. J., Valyi‐Nagy, K., Korneff, D., LoPresti, P., Woltjer, R., & Valyi‐Nagy, T. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00595.x · Cited by 38

Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease

Wood, P. L., Smith, T. M., Lane, N., Khan, M. A., Ehrmantraut, G., & Goodenowe, D. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-227 · Cited by 41

Relationships Between Diffusion Tensor Imaging and Cerebrospinal Fluid Metrics in Early Stages of the Alzheimer’s Disease Continuum

Alm, K. H., & Bakker, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181210 · Cited by 38

A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease

Davies, C. A., Morroll, D., Prinja, D., Mann, D. M. A., & Gibbs, A. C. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90057-t · Cited by 36

Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice

Zhou, L., Flores, J., Noël, A., Beauchet, O., Sjöström, P. J., & LeBlanc, A. C. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0856-6 · Cited by 36

Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine‐Derived Nitrosamine Ketone‐Associated White Matter Degeneration

Yalcin, E. B., Nuñez, K. M., Tong, M., & de la Monte, S. M. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12909 · Cited by 35

Deep brain stimulation of fornix for memory improvement in Alzheimer’s disease: A critical review

Li, R., Zhang, C., Rao, Y., & Yuan, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101668 · Cited by 34

Neuropathological quantification of dtg APP/PS1: neuroimaging, stereology, and biochemistry

Manaye, K. F., Wang, P. C., O’Neil, J. N., Huang, S., Xu, T., Lei, D.-L., Tizabi, Y., Ottinger, M. A., Ingram, D. K., & Mouton, P. R. (2007) · AGE · doi:10.1007/s11357-007-9035-y · Cited by 35

The possible role of myelin destruction as a precipitating event in Alzheimer’s disease

Noble, M. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.07.001 · Cited by 35

Magnetic Resonance Approaches to Brain Aging and Alzheimer Disease-associated Neuropathology

Anderson, V. C., Litvack, Z., & Kaye, J. A. (2005) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245458.05654.d0 · Cited by 36

Vascular changes in white matter lesions of Alzheimer's disease

Tomimoto, H., Akiguchi, I., Akiyama, H., Ikeda, K., Wakita, H., Lin, J., & Budka, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010051039 · Cited by 34

In vivo proton magnetic resonance spectroscopy study on premature aging in adult Down's syndrome

Murata, T., Koshino, Y., Omori, M., Murata, I., Nishio, M., Horie, T., Umezawa, Y., Isaki, K., Kimura, H., Itoh, S., et al. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90086-s · Cited by 35

Neuronal thread protein over-expression in brains with Alzheimer's disease lesions

de la Monte, S. M., & Wands, J. R. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90243-e · Cited by 30

Meningioma in the elderly: Characteristics, prognostic factors, and surgical strategy

Zhao, X., Zhao, D., Wu, Y., Gao, W., Cui, H., Wang, Y., Nakaji, P., & Bao, Y. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.06.011 · Cited by 29

New (Benz)Imidazolopyridino Tacrines as Nonhepatotoxic, Cholinesterase Inhibitors for Alzheimer Disease

Boulebd, H., Ismaïli, L., Martin, H., Bonet, A., Chioua, M., Marco, J. L., & Ali Belfaitah, A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0019 · Cited by 28

Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

Òbis, È., Sol, J., Andrés‐Benito, P., Martin‐Garí, M., Mota‐Martorell, N., Galo‐Licona, J. D., Piñol‐Ripoll, G., Portero‐Otín, M., Ferrer, I., Jové, M., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0217 · Cited by 28

White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

Rowley, J., Fonov, V., Wu, O., Eskildsen, S. F., Schoemaker, D., Wu, L., Mohades, S., Shin, M., Sziklas, V., Cheewakriengkrai, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074776 · Cited by 27

Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)

de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 28

Blood pressure and dementia

Martyn, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90603-0 · Cited by 27

Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer's disease?

O'Brien, J. T. (1995) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930100602 · Cited by 27

Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42 Aggregation Inhibitors for Alzheimer's Disease Therapy

Dgachi, Y., Ismaïli, L., Knez, D., Benchekroun, M., Martin, H., Szałaj, N., Wehle, S., Bautista‐Aguilera, Ó. M., Luzet, V., Bonnet, A., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201500539 · Cited by 26

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Initiative, A. D. N., Schilling, L. P., Pascoal, T. A., Zimmer, E. R., Mathotaarachchi, S. S., Shin, M., Rieder, C. R. D. M., Gauthier, S. G., Palmini, A., & Rosa‐Neto, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1405-1 · Cited by 25

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease

de la Monte, S. M., Tong, M., & Hapel, A. J. (2023) · Biomedicines · doi:10.3390/biomedicines11092394 · Cited by 28

Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer’s Disease

Roy, M., Rheault, F., Croteau, É., Castellano, C., Fortier, M., St‐Pierre, V., Houde, J., Turcotte, É. E., Bocti, C., Fülöp, T., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200213 · Cited by 23

White matter tauopathy: Transient functional loss and novel myelin remodeling

Jackson, J., Bianco, G., Rosa, A. O., Cowan, K., Bond, P., Anichtchik, O. V., & Fern, R. F. (2018) · Glia · doi:10.1002/glia.23286 · Cited by 24

Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer’s disease and cardiovascular diseases

Waigi, E. W., Webb, R. C., Moss, M. A., Uline, M. J., McCarthy, C. G., & Wenceslau, C. F. (2023) · GeroScience · doi:10.1007/s11357-023-00748-y · Cited by 26

Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive Impairment

Meyer, P., Feldkamp, H., Hoppstädter, M., King, A. V., Frölich, L., Wessa, M., & Flor, H. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00089 · Cited by 23

The Neuropathology of Alzheimer’s Disease

Lantos, P. L., & Cairns, N. J. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_12 · Cited by 23

Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer’s Disease

Nuñez, K. M., Kay, J., Krotow, A., Tong, M., Agarwal, A., Cadenas, E., & de la Monte, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150916 · Cited by 22

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Marson, F., Lasaponara, S., & Cavallo, M. (2021) · Medicina · doi:10.3390/medicina57030215 · Cited by 25

The impact of localized grey matter damage on neighboring connectivity: posterior cortical atrophy and the visual network

Glick-Shames, H., Backner, Y., Bick, A. S., Raz, N., & Levin, N. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9952-7 · Cited by 19

Brain Mapping in Dementia

Mega, M. S., Thompson, P. M., Toga, A. W., & Cummings, J. L. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50012-3 · Cited by 19

Is pharmacological prevention of Alzheimer's a realistic goal?

Anthony, J. C., Breitner, J. C. S., & Zandi, P. P. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.4.365 · Cited by 18

Alzheimer's disease

Bennett, D. A., & Evans, D. A. (1992) · Disease-a-Month · doi:10.1016/0011-5029(92)90010-m · Cited by 17

Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease

Tong, M., Leão, R. A. C., Vimbela, G. V., Yalcin, E. B., Kay, J., Krotow, A., & de la Monte, S. M. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.010 · Cited by 17

Low Cerebrospinal Fluid Aβ 42 and Aβ 40 are Related to White Matter Lesions in Cognitively Normal Elderly

Skoog, I. G., Kern, S., Zetterberg, H., Östling, S., Börjesson‐Hanson, A., Guo, X., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170950 · Cited by 18

Interactive segmentation of cerebral gray matter, white matter, and CSF: Photographic and MR images

Bartlett, T. Q., Vannier, M. W., McKeel, D. W., Gado, M. H., Hildebolt, C. F., & Walkup, R. K. (1994) · Computerized Medical Imaging and Graphics · doi:10.1016/0895-6111(94)90083-3 · Cited by 17

Oligodendrocyte degeneration in AD

Whitman, G. T., & Cotman, C. W. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.06.001 · Cited by 16

Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease

Coffman, J. A., Torello, M. W., Bornstein, R. A., Chakeres, D. W., Burns, E. M., & Nasrallah, H. A. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90422-x · Cited by 15

Lectin-histochemical detection of degenerative glycoconjugate deposits in human brain

Nishimura, A., Sawada, S., Ushiyama, I., Yamamoto, Y., Nakagawa, T., Tanegashima, A., & Nishi, K. (2000) · Forensic Science International · doi:10.1016/s0379-0738(00)00228-0 · Cited by 15

Alzheimer's disease amyloid precursor protein is present in the myelin sheath of central nervous system in rat

Ikeda, K., & Tomonaga, M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91072-o · Cited by 14

Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence

Stepanchuk, A. A., Barber, P. A., Lashley, T., Joseph, J. T., & Stys, P. K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105540 · Cited by 13

No change in total length of white matter fibers in Alzheimer's disease

Jørgensen, A.-M. B., Marner, L., & Pakkenberg, B. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.075 · Cited by 13

Tract-Based Spatial Statistics: Application to Mild Cognitive Impairment

Wai, Y., Hsu, W., Fung, H., Lee, J.-D., Chan, H., Tsai, M.-L., Lin, Y.-C., Wu, Y., Ying, L. L., & Wang, J. (2014) · BioMed Research International · doi:10.1155/2014/713079 · Cited by 12

White matter dementia then… and now

Filley, C. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1043583 · Cited by 11

Insights from simultaneous EEG-fMRI and patient data illuminate the role of the anterior medial temporal lobe in N400 generation

Meyer, P., Baeuchl, C., & Hoppstädter, M. (2023) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2023.108762 · Cited by 11

β‐Amyloid precursor protein of Alzheimer's disease in cultured bovine oligodendrocytes

Mizuguchi, M., Ikeda, K., & Kim, S. U. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320105 · Cited by 11

Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease

Cantero, J. L., Atienza, M., Sánchez‐Juan, P., Rodríguez‐Rodríguez, E., Vázquez‐Higuera, J. L., Pozueta, A., González‐Suárez, A., Vilaplana, E., Pegueroles, J., Montal, V., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.010 · Cited by 11

Topography of Lesions in Alzheimer’s Disease: A Challenge to Morphologists

Hauw, J., Duyckaerts, C. J., Delaère, P., & Piette, F. (1990) · Springer eBooks · doi:10.1007/978-3-642-75690-0_4 · Cited by 11

The Early Detection of Brain Pathology in Alzheimer’s Disease

de Leon, M. J., Smith, G. S., Convit, A. J., GEORGE, A. E., Golomb, J. B., Flicker, C., McRae, T., Kluger, A., Tsui, W., Rusinek, H., et al. (1992) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-46759-2_11 · Cited by 11

Understanding Guillain-Barré Syndrome and Central Nervous System Involvement

Gregory, M., Gregory, R. J., & Podd, J. (2005) · Rehabilitation Nursing · doi:10.1002/j.2048-7940.2005.tb00112.x · Cited by 9

MRI Volumetric Studies in Alzheimer's Disease: Relationship to Clinical and Neuropsychological Variables

Kumar, A. A., Newberg, A. B., Alavi, A. A., Moberg, P. J., Berlin, J. A., Miller, D., Souder, E., Gur, R. E., & Gottlieb, G. L. (1994) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199400210-00005 · Cited by 9

Leuko-araiosis: a reappraisal. I. CT studies

Inzitari, D., & Mascalchi, M. (1990) · Neurological Sciences · doi:10.1007/bf02333853 · Cited by 9

The Leukocentric Theory of Neurological Disorder: A Manifesto

Fern, R. F. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2279-8 · Cited by 8

A Comprehensive Review of Herbal Medicines for the Treatment of Alzheimer's Disease

Shadab, S., Rao, G. K., Paliwal, D., Yadav, D., Alam, A., Singh, A., & Sultana, M. J. (2023) · Current Traditional Medicine · doi:10.2174/2215083810666230608151821 · Cited by 7

Neuropathology of Alzheimer’s disease in Down syndrome

Mann, D. M. A. (2018) · CRC Press eBooks · doi:10.1201/9781315376875-2 · Cited by 6

Diffusion tensor studies and voxel-based morphometry of the temporal lobe to determine the cognitive prognosis in cases of Alzheimer’s disease and mild cognitive impairment: Do white matter changes precede gray matter changes?

Taoka, T., Yasuno, F., Morikawa, M., Inoue, M., Kiuchi, K., Kitamura, S., Matsuoka, K., Kishimoto, T., Kichikawa, K., & Naganawa, S. (2016) · SpringerPlus · doi:10.1186/s40064-016-2692-5 · Cited by 6

The Oligodendrocyte

Noble, M., Mayer‐Pröschel, M., & Miller, R. H. (2006) · Kluwer Academic Publishers-Plenum Publishers eBooks · doi:10.1007/0-387-28117-7_6 · Cited by 6

Tissue Microarray Lipidomic Imaging Mass Spectrometry Method: Application to the Study of Alcohol-Related White Matter Neurodegeneration

Gameiro‐Ros, I., Noble, L. C., Tong, M., Yalcin, E. B., & de la Monte, S. M. (2023) · Applied Biosciences · doi:10.3390/applbiosci2020013 · Cited by 5

THE NEUROPATHOLOGY OF ALZHEIMER'S DISEASE

Wisniewski, H. M., & Węgiel, J. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00275-8 · Cited by 7

Brain Atrophy in Neurodegenerative Diseases

Pirttilä, T., Järvenpää, R., Dastidar, P., & Frey, H. (1993) · Acta Radiologica · doi:10.1177/028418519303400318 · Cited by 5

Insulin Resistance and Oligodendrocyte/Microvascular Endothelial Cell Dysfunction as Mediators of White Matter Degeneration in Alzheimer’s Disease

de la Monte, S. M., & Grammas, P. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch8 · Cited by 7

Clinico-pathological correlation in dementias.

Teixeira, F., Alonso, E., Romero, V. G., Ortíz, A., Martínez, C., & Otero, E. (1995) · PubMed Central · Cited by 5

Insulin Resistance, Cognitive Impairment and Neurodegeneration: Roles of Nitrosamine Exposure, Diet and Lifestyles

de la Monte, S., Tong, M., & Jack, R. (2011) · InTech eBooks · doi:10.5772/17682 · Cited by 5

Axonal Tract Tracing For Delineating Interacting Brain Regions: Implications For Alzheimer‘s Disease-Associated Memory

van Groen, T., Miettinen, P., & Kadish, I. (2013) · Future Neurology · doi:10.2217/fnl.13.67 · Cited by 5

Comparative Brain and Serum Exosome Expression of Biomarkers in an Experimental Model of Alzheimer-Type Neurodegeneration: Potential Relevance to Liquid Biopsy Diagnostics

de la Monte, S. M., Yang, Y., Prabhu, A., & Tong, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094190 · Cited by 4

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance

Huang, Y., Chan, H., Khoo, J.-Y., Chan, M.-L., Bender, D. A., Ponnusamy, V. K., Belaidi, A. A., & Ke, L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106104 · Cited by 4

Comparative Analysis of Lipid Extracts and Imaging Mass Spectrometry for Evaluating Cerebral White Matter Biochemical Pathology in an Experimental Second-Hand Cigarette Smoke Exposure Model

Krotow, A., & Yalcin, E. B. (2016) · Mass Spectrometry & Purification Techniques · doi:10.4172/2469-9861.1000113 · Cited by 4

Pathologic issues and new methodologies in the evaluation of non-Alzheimer dementias

Vinters, H. V., Klement, I. A., Sung, S. H., & Farag, E. S. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.007 · Cited by 4

Maladie d’alzheimer, hippocampe et neuroimagerie

Mevel, K., Chételat, G., Desgranges, B., & Eustache, F. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76306-0 · Cited by 4

Quantitative CT scan analysis in senile dementia of the Alzheimer type: II. Radioattentuation of grey and white matter

Förstl, H., Burns, A. S., Jacoby, R. J., Eagger, S. A., & Levy, R. (1991) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930061005 · Cited by 4

Dynamic Mapping of Alzheimer’s Disease

Thompson, P. M., Hayashi, K. M., de Zubicaray, G. I., Janke, A. L., Sowell, E. R., Rose, S., Semple, J. M., Herman, D. H., Hong, M., Dittmer, S. S., et al. (2004) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-59300-0_8 · Cited by 4

Neuropathological substrate of dementia in Parkinson's disease

Jellinger, K. A. (1990) · Annals of Neurology · doi:10.1002/ana.410280522 · Cited by 3

Effect of advanced brain atrophy and vitamin deficiency on cognitive functions in non-demented subjects

Pirttilä, T., Salo, J., Laippala, P. J., & Frey, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04094.x · Cited by 3

Alzheimer's disease or A lzheimer's syndrome?: a longitudinal computed tomography neuroradiological follow‐up study of 56 cases diagnosed clinically as A lzheimer's disease

Fujisawa, K., Tsunoda, S., Hino, H., Shibuya, K., Takeda, A., & Aoki, N. (2015) · Psychogeriatrics · doi:10.1111/psyg.12162 · Cited by 3

Elevated Blood Pressure and Alzheimer's Disease

Skoog, I. G. (1997) · Hospital Practice · doi:10.1080/21548331.1997.11443458 · Cited by 3

Spatial relationships between white matter degeneration, amyloid load and cortical volume in amnestic mild cognitive impairmentPreprint

Jelescu, I., Shepherd, T. M., Novikov, D. S., Ding, Y., Ades‐Aron, B., Smith, J. M., Vahle, T., Babb, J. S., Friedman, K. P., de Leon, M. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/441840 · Cited by 3

Computed tomography and magnetic resonance imaging in the diagnosis of Alzheimer’s disease

Aichner, F., Felber, S. R., & Birbamer, G. (1994) · Key topics in brain research · doi:10.1007/978-3-7091-9376-1_3 · Cited by 3

Correction: White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

Rowley, J., Fonov, V., Wu, O., Eskildsen, S. F., Schoemaker, D., Wu, L., Mohades, S., Shin, M., Sziklas, V., Cheewakriengkrai, L., et al. (2013) · PLoS ONE · doi:10.1371/annotation/c1e8aa6c-5e8a-4938-a0ed-1a7dc5ead757 · Cited by 3

Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.

de la Monte, S. M., Spratt, R. A., Chong, J. K., Ghanbari, H. A., & Wands, J. R. (1992) · PubMed · Cited by 3

Morphometric Measurements of MRI Findings in Patients with Alzheimer’s Disease

Yücel, F., Yaman, S., Özbabalık, D., Özkan, S., Ortuğ, G., & Özdemır, G. (2014) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/37028 · Cited by 2

White Matter Dementia: Origin, Development, Progress, and Prospects

Filley, C. M. (2016) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16010003 · Cited by 3

Blood Brain Barrier Dysfunction and Cerebrovascular Degeneration in Alzheimer’s Disease

Kalaria, R. N. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_11 · Cited by 2

S4–02–03: Cortical and sub–cortical changes in preclinical and clincial stages of Alzheimer's disease assessed with magnetic resonance imaging

Teipel, S. J., Schönberg, S. O., Flatz, W. H., Schapiro, M. B., Alexander, G. E., Reiser, M. F., Möller, H., Rapoport, S. I., & Hampel, H. J. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.272

In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease

Hampel, H. J., Teipel, S. J., Alexander, G. E., Pogarell, O. M., Рапопорт, С. И., & Möller, H. ‐. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200069 · Cited by 89

P2‐195: GREY MATTER ATROPHY AND WHITE MATTER DISEASE IN ALZHEIMER'S DEMENTIA

Ng, A. Y. T., Chander, R. J., Wen, M., & Kandiah, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.871

White Matter Degeneration in Atypical Alzheimer Disease

Caso, F., Agosta, F., Mattavelli, D., Migliaccio, R., Canu, E., Magnani, G., Marcone, A., Copetti, M., Falautano, M., Comı, G., et al. (2015) · Radiology · doi:10.1148/radiol.2015142766 · Cited by 69

Callosal atrophy in Mild Cognitive Impairment and Alzheimer’s Disease: Different effects in different stages

di Paola, M., Luders, E., di Iulio, F., Cherubini, A., Passafiume, D., Thompson, P., Caltagirone, C., Toga, A., & Spalletta, G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.050 · Cited by 111